Building on CBD's proven anticonvulsant properties, a growing body of preclinical and clinical evidence suggests it may also help treat depression, anxiety, PTSD, addiction, and autism spectrum disorder.
People interested in CBD for mental health conditions, clinicians following cannabinoid therapeutics, epilepsy patients and families
CBD is FDA-approved for epilepsy with growing evidence for other neuropsychiatric uses
What the researchers found
Strong evidence supports CBD's anticonvulsant properties for epilepsy, and accumulating research suggests promising effects for depression, anxiety, PTSD, addiction, neurodegenerative disorders, and autism. The review highlights contributions from Brazilian researchers who pioneered CBD epilepsy research.
Why it matters
The FDA approval of CBD for epilepsy created a regulatory pathway that could be replicated for other neuropsychiatric conditions if clinical evidence continues to build.
The numbers in context
CBD-based Epidiolex approved for Dravet's syndrome and Lennox-Gastaut syndrome; studies span depression, anxiety, PTSD, addiction, neurodegeneration, and autism
How the study worked
Narrative review of preclinical and clinical data on CBD for epilepsy and neuropsychiatric disorders, with historical context of Brazilian cannabinoid research.
What this study cannot tell us
Much evidence for non-epilepsy conditions remains preclinical. Clinical trials for neuropsychiatric indications are generally smaller and less rigorous than epilepsy trials. Optimal dosing for different conditions is unclear.
How to read the evidence
Narrative review covering strong epilepsy evidence alongside preliminary data for other conditions
When this study was published
Published in 2021. Clinical trials for CBD in neuropsychiatric conditions continue to expand.
The bigger picture
CBD's journey from folk medicine to FDA-approved epilepsy treatment represents a model for how other cannabinoid-based therapeutics might gain mainstream medical acceptance.
Questions still open
- Which neuropsychiatric condition has the strongest evidence for CBD efficacy beyond epilepsy? Will CBD need different formulations or doses for different psychiatric conditions?
Common questions
Could CBD treat mental health conditions beyond epilepsy?
How did CBD become an approved epilepsy treatment?
Read the original research
From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?
Frontiers in psychiatry, 12, 638032
Citation
Bitencourt, Rafael M; Takahashi, Reinaldo N; Carlini, Elisaldo A. (2021). From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?. Frontiers in psychiatry, 12, 638032. https://doi.org/10.3389/fpsyt.2021.638032
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk